Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
Latest Optive AI™ software receives CE mark and UKCA approvals, supporting the ongoing Swoop system Model 2 rollout, already underway in four international markets; "Notes and Neurons" showcases portable brain
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
Preliminary Revenue Represents 53% Sequential Quarterly Growth; Company Reaffirms 2026 Financial Guidance and Expects Quarter-End Cash and Cash Equivalents of Approximately $37.9 Million
Hyperfine, Inc.
Hyperfine has appointed Roots Pharmaceutical as exclusive distributor of the Swoop® system for Kuwait and the United Arab EmiratesHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has
The anticipated indication expansion would position Hyperfine to drive adoption in outpatient neurology and establish new opportunities for portable MRI in post-procedural imaging in operating room
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
Peer-reviewed clinical results and strong patient preference support growing use across neurology practices and emerging brain health applications
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology
This newest software delivers improved image quality across Swoop system sequences, a more intuitive scanning experience, and new foundational isotropic imaging designed to strengthen the clinical utility of portable
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop®
Recent publications in the prominent Journal of Neurosurgery and Stroke provide new evidence supporting the clinical value of the Swoop system in stroke care and neurosurgical settings.
Hyperfine, Inc. (NASDAQ:HYPR),
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced
Hyperfine has initiated the launch of the next-generation Swoop® system in European markets, beginning the global expansion of its most advanced portable MRI technology.
Hyperfine, Inc. (NASDAQ:HYPR), the
Leading neurosurgeons from around the world will help guide the role of the Swoop® system in neurosurgical care, including surgical workflow, product capabilities, and clinical evidence.
Hyperfine, Inc.
